These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 21703916)
21. Effect of cyclodextrin nanocavity confinement on the photorelaxation of the cardiotonic drug milrinone. El-Kemary M; Organero JA; Santos L; Douhal A J Phys Chem B; 2006 Jul; 110(29):14128-34. PubMed ID: 16854110 [TBL] [Abstract][Full Text] [Related]
22. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation. Garnero C; Zoppi A; Genovese D; Longhi M Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225 [TBL] [Abstract][Full Text] [Related]
23. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex. Jadhav GS; Vavia PR Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545 [TBL] [Abstract][Full Text] [Related]
24. Comparative study on the inclusion behavior between meso-tetrakis(4-N-ethylpyridiniurmyl)porphyrin and beta-cyclodextrin derivatives. Xiliang G; Shaomin S; Chuan D; Feng F; Wong MS Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(3):413-8. PubMed ID: 15582808 [TBL] [Abstract][Full Text] [Related]
25. UV-vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with beta-cyclodextrins. Crupi V; Ficarra R; Guardo M; Majolino D; Stancanelli R; Venuti V J Pharm Biomed Anal; 2007 May; 44(1):110-7. PubMed ID: 17379467 [TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations. Villaverde J; Morillo E; Pérez-Martínez JI; Ginés JM; Maqueda C J Agric Food Chem; 2004 Feb; 52(4):864-9. PubMed ID: 14969543 [TBL] [Abstract][Full Text] [Related]
27. Physicochemical characterisation of the supramolecular structure of luteolin/cyclodextrin inclusion complex. Liu B; Li W; Zhao J; Liu Y; Zhu X; Liang G Food Chem; 2013 Nov; 141(2):900-6. PubMed ID: 23790865 [TBL] [Abstract][Full Text] [Related]
29. Spectral characteristics of tramadol in different solvents and beta-cyclodextrin. Anton Smith A; Manavalan R; Kannan K; Rajendiran N Spectrochim Acta A Mol Biomol Spectrosc; 2009 Oct; 74(2):469-77. PubMed ID: 19665424 [TBL] [Abstract][Full Text] [Related]
30. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex. Patil AL; Pore YV; Kuchekar BS; Late SG Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387 [TBL] [Abstract][Full Text] [Related]
31. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative. Jug M; Kosalec I; Maestrelli F; Mura P J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544 [TBL] [Abstract][Full Text] [Related]
32. Study on the inclusion behavior between meso-tetrakis[4-(3-pyridiniumpropoxy)phenyl]prophyrin tetrakisbromide and beta-cyclodextrin derivatives in aqueous solution. Qiu WG; Li ZF; Bai GM; Meng SN; Dai HX; He H Spectrochim Acta A Mol Biomol Spectrosc; 2007 Apr; 66(4-5):1189-93. PubMed ID: 17251055 [TBL] [Abstract][Full Text] [Related]
33. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. Jug M; Maestrelli F; Bragagni M; Mura P J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541 [TBL] [Abstract][Full Text] [Related]
34. [Study of the characterization of beta-cyclodextrin-acetylferrocene-thiosemicarbazone inclusion complex and micro-environmental effects]. Zhang J; Liu WY; Zhang X Guang Pu Xue Yu Guang Pu Fen Xi; 2005 Oct; 25(10):1568-72. PubMed ID: 16395884 [TBL] [Abstract][Full Text] [Related]
35. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin. Guo B; Zhong S; Li N; Li X; Yi J; Jin M Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855 [TBL] [Abstract][Full Text] [Related]
36. Preparation of the β-cyclodextrin-vitamin C (β-CD-Vc) inclusion complex under high hydrostatic pressure (HHP). Hu X; Wei B; Li H; Wu C; Bai Y; Xu X; Jin Z; Tian Y Carbohydr Polym; 2012 Oct; 90(2):1193-6. PubMed ID: 22840058 [TBL] [Abstract][Full Text] [Related]
37. Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex. de Araujo DR; Tsuneda SS; Cereda CM; Del G F Carvalho F; Preté PS; Fernandes SA; Yokaichiya F; Franco MK; Mazzaro I; Fraceto LF; de F A Braga A; de Paula E Eur J Pharm Sci; 2008 Jan; 33(1):60-71. PubMed ID: 18036789 [TBL] [Abstract][Full Text] [Related]
38. Investigation of inclusion complex of epothilone A with cyclodextrins. Xiao CF; Li K; Huang R; He GJ; Zhang JQ; Zhu L; Yang QY; Jiang KM; Jin Y; Lin J Carbohydr Polym; 2014 Feb; 102():297-305. PubMed ID: 24507285 [TBL] [Abstract][Full Text] [Related]
39. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems. Onyeji CO; Omoruyi SI; Oladimeji FA Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103 [TBL] [Abstract][Full Text] [Related]
40. Host-guest inclusion complex of propafenone hydrochloride with α- and β-cyclodextrins: spectral and molecular modeling studies. Siva S; Thulasidhasan J; Rajendiran N Spectrochim Acta A Mol Biomol Spectrosc; 2013 Nov; 115():559-67. PubMed ID: 23872014 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]